Adagrasib
Healthy Adults
Mirati Therapeutics Inc.Small moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Healthy Adults cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Probenecid Pfizer | Phase 1 | CC |
Atirmociclib Pfizer | Phase 1 | CC |
sb-497115-gr Mirati Therapeutics Inc. | Phase 1 | CC |
Itraconazole Pfizer | Phase 1 | CC |
Same molecule, other indications
Adagrasib is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →